Bleeding News and Research

RSS

URMC research confirms possible use of mifepristone for painful fibroids

Research continues to show that the controversial abortion drug mifepristone might have another use, as a therapeutic option besides hysterectomy for women who suffer from severe symptoms associated with uterine fibroids.

8 Mar 2011

Grifols receives FDA approval for Alphanate to treat vCJD

Grifols, a global healthcare company and biopharmaceutical manufacturer based in Barcelona, Spain today announced that it received approval from the US Food and Drug Administration for revised labeling for Alphanate Antihemophilic Factor/von Willebrand Factor Complex indicating that certain manufacturing steps have been shown to reduce the infectivity of a experimental TSE agent that is a model for variant Creutzfeldt Jakob Disease.

5 Mar 2011

Volcano launches Platinum digital IVUS catheter at PCI Live Demonstration Course in Kurashiki

Volcano Corporation, a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it received clearance to market the Eagle Eye Platinum digital IVUS catheter in Japan, and will introduce the device at the 20th PCI Live Demonstration Course in Kurashiki, which starts on March 3rd.

4 Mar 2011

Study reveals expansion of NK cells after acute infection

The natural killer cells of our immune defense are activated for an extended period after the acute infection, which challenges the prevailing view that the elevation and activation of cells quickly pass.

3 Mar 2011

WARFARIN study to explore impact of genetic testing on individualized dosing

Iverson Genetic Diagnostics, Inc. announced today that the WARFARIN Study was initiated in major hospital systems nationwide to assess the utility of genetic testing to determine a personalized warfarin dose for individual patients to reduce their risk of serious bleeding or clotting events.

2 Mar 2011

Uterine fibroid treatments greatly improve quality of life in women

Women who received one of three treatments for uterine fibroids at Brigham and Women's Hospital in Boston said their symptoms diminished and their quality of life significantly increased, according to a new study published in the May issue of Radiology.

1 Mar 2011

New process automatically ensures optimum tension for sutures in minimally invasive surgeries

More and more often, abdominal surgeries are being carried out in a minimally invasive manner. A small incision in the abdominal wall is sufficient for the surgeon to be able to insert the instrument and make the organs visible with an endoscope. This technique is gentler and does not stress the body as much as traditional surgeries do.

1 Mar 2011

CTSI awards NYU one-year pilot grant to assess feasibility of hemoglobin A1C diabetes test

New York University's Clinical and Translational Science Institute has awarded an NYU nursing-dental research team a one-year pilot grant to assess the feasibility of using gingival crevicular blood from periodontal patients to gauge hemoglobin A1C -- a blood glucose measurement -- as a means of diagnosing diabetes and identifying pre-diabetes.

28 Feb 2011

Medtronic acquires chitosan-dextran gel technology for use in functional endoscopic sinus surgery

Medtronic, Inc. today announced that it has completed the purchase of rights to a chitosan-dextran gel technology from Adelaide Research & Innovation Pty Ltd. in Australia, Robinson Squidgel Ltd., and Otago Innovation Ltd. in New Zealand. Medtronic is acquiring this technology for potential use in developing future products for functional endoscopic sinus surgery (FESS).

25 Feb 2011

Journal of Clinical Virology publishes positive outcome from CMX001 treatment against AdV infection

Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced the publication of the first reported case in which adenovirus infection was successfully eradicated following treatment with its broad-spectrum antiviral drug, CMX001.

25 Feb 2011

Omega-3 fish oils: Natural health solution for the heart

Did you know that over the average life span, a heart beats 2 to 3 billion times? As one of the hardest working muscles pumping oxygen and essential nutrients throughout your body an average of 100,000 times a day, the heart needs a lot of help to stay working fit.

25 Feb 2011

First patient enrolled in TXA127 Phase 2 clinical study to stimulate engraftment following transplant

Tarix Pharmaceuticals today announced enrollment of the first patient in a Phase 2 clinical study of TXA127, a pharmaceutical grade formulation of a naturally occurring peptide known to stimulate early hematopoietic precursor cells in the bone marrow.

24 Feb 2011

Novo Nordisk submits rFXIII BLA to FDA for treatment of inherited bleeding disorder

Novo Nordisk announced today that a Biologic License Application has been submitted to the U.S. Food and Drug Administration requesting the approval of a recombinant factor XIII compound for the vast majority of patients with congenital factor XIII deficiency, an inherited bleeding disorder.

From Novo Nordisk 23 Feb 2011

Aspirin for coronary heart prevention is less costly, more effective

Using aspirin for coronary heart prevention is less costly and more effective than doing nothing in men older than 45 with more than 10 percent 10-year-risk of the disease, according to a study by researchers at RTI International, University of Michigan, and University of North Carolina at Chapel Hill.

23 Feb 2011

Study: Gender may not increase risk of heart attack deaths

A study led by the University of Michigan Cardiovascular Center shows being a woman may not increase your risk of dying from treatment for a severe heart attack.

21 Feb 2011

$Tip sheets provide details on hip and knee fracture treatment$

Tip sheets provide details on hip and knee fracture treatment

Patients who wait more than 36 hours for surgery to correct a hip fracture have a 39 percent rate of medical complication and those who wait 48 hours have a 46 percent complication rate. Patients who receive surgical treatment within 24 hours have a lower complication rate of 25 percent and a shorter hospital stay. Each day the surgery was delayed added an additional two days to hospital stay.

21 Feb 2011

New study shows low doses of aspirin can significantly reduce risk of cancers

A new study by scientists from Oxford, Edinburgh, London and Japan shows that at low doses, aspirin can significantly reduce the risk of a range of cancers.

20 Feb 2011

FDA grants CSL Behring marketing approval for Corifact in treatment of congenital FXIII deficiency

CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Corifact™, Factor XIII Concentrate (Human), for the routine prophylactic treatment of congenital factor XIII (FXIII) deficiency. Corifact, already available for use in 12 countries throughout the world under the trade name Fibrogammin®- P, is the first and only FXIII concentrate approved in the U.S.

19 Feb 2011

Inducing labor is linked with negative outcomes for mother, does not provide benefit to newborn

Inducing labor without a medical reason is associated with negative outcomes for the mother, including increased rates of cesarean delivery, greater blood loss and an extended length of stay in the hospital, and does not provide any benefit for the newborn.

19 Feb 2011

$Helmets reduce skull fractures in skiers, snowboarders$

Helmets reduce skull fractures in skiers, snowboarders

A compelling clinical article published online in the March 2011 issue of Journal of Neurosurgery: Pediatrics, entitled Helmet Use Reduces Skull Fractures in Skiers and Snowboarders Admitted to the Hospital discusses skull fractures incurred by young skiers and snowboarders and the role helmets play in reducing these head injuries.

18 Feb 2011

Bleeding News and Research

URMC research confirms possible use of mifepristone for painful fibroids

Grifols receives FDA approval for Alphanate to treat vCJD

Volcano launches Platinum digital IVUS catheter at PCI Live Demonstration Course in Kurashiki

Study reveals expansion of NK cells after acute infection

WARFARIN study to explore impact of genetic testing on individualized dosing

Uterine fibroid treatments greatly improve quality of life in women

New process automatically ensures optimum tension for sutures in minimally invasive surgeries

CTSI awards NYU one-year pilot grant to assess feasibility of hemoglobin A1C diabetes test

Medtronic acquires chitosan-dextran gel technology for use in functional endoscopic sinus surgery

Journal of Clinical Virology publishes positive outcome from CMX001 treatment against AdV infection

Omega-3 fish oils: Natural health solution for the heart

First patient enrolled in TXA127 Phase 2 clinical study to stimulate engraftment following transplant

Novo Nordisk submits rFXIII BLA to FDA for treatment of inherited bleeding disorder

Aspirin for coronary heart prevention is less costly, more effective

Study: Gender may not increase risk of heart attack deaths

Tip sheets provide details on hip and knee fracture treatment

New study shows low doses of aspirin can significantly reduce risk of cancers

FDA grants CSL Behring marketing approval for Corifact in treatment of congenital FXIII deficiency

Inducing labor is linked with negative outcomes for mother, does not provide benefit to newborn

Helmets reduce skull fractures in skiers, snowboarders

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News